REPORT ID 6267

EMEA (Europe, Middle East and Africa) Polio Vaccine Market Report 2017

Publish Date
25-Dec-17
Pages
113
Format
Electronic (PDF)

In this report, the EMEA Polio Vaccine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Pcs), revenue (Million USD), market share and growth rate of Polio Vaccine for these regions, from 2012 to 2022 (forecast)
    Europe: Germany, France, UK, Russia, Italy and Benelux;
    Middle East: Saudi Arabia, Israel, UAE and Iran;
    Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Polio Vaccine market competition by top manufacturers/players, with Polio Vaccine sales volume (K Pcs), price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including
    GSK
    Bibcol
    Sanofi
    Merck & Co
    Pfizer
    Beijing Tiantan Biological
    Bio-Med
    Panacea Biotec Ltd
    Adithya Vaccine Pharma
    Sinovac Biotech Ltd
    IPOL
    Halfkin Bio-Pharmaceuticals Corporation Ltd
    Aventis Pasteur

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
    By Type
        Inactivated Polio Vaccine (IPV)
        Oral Polio Vaccine (OPV)
    By Type 2
        Live Attenuated Vaccine
        Inactivated Vaccine

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Hospital
    Clinics
    Public Services
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

EMEA (Europe, Middle East and Africa) Polio Vaccine Market Report 2017
1 Polio Vaccine Overview
    1.1 Product Overview and Scope of Polio Vaccine
    1.2 Classification of Polio Vaccine
        1.2.1 EMEA Polio Vaccine Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 EMEA Polio Vaccine Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Inactivated Polio Vaccine (IPV)
        1.2.4 Oral Polio Vaccine (OPV)
    1.3 EMEA Polio Vaccine Market by Application/End Users
        1.3.1 EMEA Polio Vaccine Sales (Volume) and Market Share Comparison by Application (2012-2022
        1.3.2 Hospital
        1.3.3 Clinics
        1.3.4 Public Services
        1.3.5 Others
    1.4 EMEA Polio Vaccine Market by Region
        1.4.1 EMEA Polio Vaccine Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 Europe Status and Prospect (2012-2022)
        1.4.3 Middle East Status and Prospect (2012-2022)
        1.4.4 Africa Status and Prospect (2012-2022)
    1.5 EMEA Market Size (Value and Volume) of Polio Vaccine (2012-2022)
        1.5.1 EMEA Polio Vaccine Sales and Growth Rate (2012-2022)
        1.5.2 EMEA Polio Vaccine Revenue and Growth Rate (2012-2022)

2 EMEA Polio Vaccine Competition by Manufacturers/Players/Suppliers, Region, Type and Application
    2.1 EMEA Polio Vaccine Market Competition by Players/Manufacturers
        2.1.1 EMEA Polio Vaccine Sales Volume and Market Share of Major Players (2012-2017)
        2.1.2 EMEA Polio Vaccine Revenue and Share by Players (2012-2017)
        2.1.3 EMEA Polio Vaccine Sale Price by Players (2012-2017)
    2.2 EMEA Polio Vaccine (Volume and Value) by Type/Product Category
        2.2.1 EMEA Polio Vaccine Sales and Market Share by Type (2012-2017)
        2.2.2 EMEA Polio Vaccine Revenue and Market Share by Type (2012-2017)
        2.2.3 EMEA Polio Vaccine Sale Price by Type (2012-2017)
    2.3 EMEA Polio Vaccine (Volume) by Application
    2.4 EMEA Polio Vaccine (Volume and Value) by Region
        2.4.1 EMEA Polio Vaccine Sales and Market Share by Region (2012-2017)
        2.4.2 EMEA Polio Vaccine Revenue and Market Share by Region (2012-2017)
        2.4.3 EMEA Polio Vaccine Sales Price by Region (2012-2017)

3 Europe Polio Vaccine (Volume, Value and Sales Price), by Players, Countries, Type and Application
    3.1 Europe Polio Vaccine Sales and Value (2012-2017)
        3.1.1 Europe Polio Vaccine Sales Volume and Growth Rate (2012-2017)
        3.1.2 Europe Polio Vaccine Revenue and Growth Rate (2012-2017)
    3.2 Europe Polio Vaccine Sales and Market Share by Type
    3.3 Europe Polio Vaccine Sales and Market Share by Application
    3.4 Europe Polio Vaccine Sales Volume and Value (Revenue) by Countries
        3.4.1 Europe Polio Vaccine Sales Volume by Countries (2012-2017)
        3.4.2 Europe Polio Vaccine Revenue by Countries (2012-2017)
        3.4.3 Germany Polio Vaccine Sales and Growth Rate (2012-2017)
        3.4.4 France Polio Vaccine Sales and Growth Rate (2012-2017)
        3.4.5 UK Polio Vaccine Sales and Growth Rate (2012-2017)
        3.4.6 Russia Polio Vaccine Sales and Growth Rate (2012-2017)
        3.4.7 Italy Polio Vaccine Sales and Growth Rate (2012-2017)
        3.4.8 Benelux Polio Vaccine Sales and Growth Rate (2012-2017)

4 Middle East Polio Vaccine (Volume, Value and Sales Price), by Region, Type and Application
    4.1 Middle East Polio Vaccine Sales and Value (2012-2017)
        4.1.1 Middle East Polio Vaccine Sales Volume and Growth Rate (2012-2017)
        4.1.2 Middle East Polio Vaccine Revenue and Growth Rate (2012-2017)
    4.2 Middle East Polio Vaccine Sales and Market Share by Type
    4.3 Middle East Polio Vaccine Sales and Market Share by Application
    4.4 Middle East Polio Vaccine Sales Volume and Value (Revenue) by Countries
        4.4.1 Middle East Polio Vaccine Sales Volume by Countries (2012-2017)
        4.4.2 Middle East Polio Vaccine Revenue by Countries (2012-2017)
        4.4.3 Saudi Arabia Polio Vaccine Sales and Growth Rate (2012-2017)
        4.4.4 Israel Polio Vaccine Sales and Growth Rate (2012-2017)
        4.4.5 UAE Polio Vaccine Sales and Growth Rate (2012-2017)
        4.4.6 Iran Polio Vaccine Sales and Growth Rate (2012-2017)

5 Africa Polio Vaccine (Volume, Value and Sales Price) by Players, Countries, Type and Application
    5.1 Africa Polio Vaccine Sales and Value (2012-2017)
        5.1.1 Africa Polio Vaccine Sales Volume and Growth Rate (2012-2017)
        5.1.2 Africa Polio Vaccine Revenue and Growth Rate (2012-2017)
    5.2 Africa Polio Vaccine Sales and Market Share by Type
    5.3 Africa Polio Vaccine Sales and Market Share by Application
    5.4 Africa Polio Vaccine Sales Volume and Value (Revenue) by Countries
        5.4.1 Africa Polio Vaccine Sales Volume by Countries (2012-2017)
        5.4.2 Africa Polio Vaccine Revenue by Countries (2012-2017)
        5.4.3 South Africa Polio Vaccine Sales and Growth Rate (2012-2017)
        5.4.4 Nigeria Polio Vaccine Sales and Growth Rate (2012-2017)
        5.4.5 Egypt Polio Vaccine Sales and Growth Rate (2012-2017)
        5.4.6 Algeria Polio Vaccine Sales and Growth Rate (2012-2017)

6 EMEA Polio Vaccine Manufacturers/Players Profiles and Sales Data
    6.1 GSK
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Polio Vaccine Product Type, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 GSK Polio Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Bibcol
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 Polio Vaccine Product Type, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Bibcol Polio Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Sanofi
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 Polio Vaccine Product Type, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Sanofi Polio Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Merck & Co
        6.4.1 Company Basic Information, Manufacturing Base and Competitors
        6.4.2 Polio Vaccine Product Type, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Merck & Co Polio Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Pfizer
        6.5.1 Company Basic Information, Manufacturing Base and Competitors
        6.5.2 Polio Vaccine Product Type, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Pfizer Polio Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Beijing Tiantan Biological
        6.6.1 Company Basic Information, Manufacturing Base and Competitors
        6.6.2 Polio Vaccine Product Type, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Beijing Tiantan Biological Polio Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Bio-Med
        6.7.1 Company Basic Information, Manufacturing Base and Competitors
        6.7.2 Polio Vaccine Product Type, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Bio-Med Polio Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 Panacea Biotec Ltd
        6.8.1 Company Basic Information, Manufacturing Base and Competitors
        6.8.2 Polio Vaccine Product Type, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Panacea Biotec Ltd Polio Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 Adithya Vaccine Pharma
        6.9.1 Company Basic Information, Manufacturing Base and Competitors
        6.9.2 Polio Vaccine Product Type, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 Adithya Vaccine Pharma Polio Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview
    6.10 Sinovac Biotech Ltd
        6.10.1 Company Basic Information, Manufacturing Base and Competitors
        6.10.2 Polio Vaccine Product Type, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 Sinovac Biotech Ltd Polio Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
        6.10.4 Main Business/Business Overview
    6.11 IPOL
    6.12 Halfkin Bio-Pharmaceuticals Corporation Ltd
    6.13 Aventis Pasteur

7 Polio Vaccine Manufacturing Cost Analysis
    7.1 Polio Vaccine Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Polio Vaccine

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Polio Vaccine Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Polio Vaccine Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 EMEA Polio Vaccine Market Forecast (2017-2022)
    11.1 EMEA Polio Vaccine Sales, Revenue and Price Forecast (2017-2022)
        11.1.1 EMEA Polio Vaccine Sales and Growth Rate Forecast (2017-2022)
        11.1.2 EMEA Polio Vaccine Revenue and Growth Rate Forecast (2017-2022)
        11.1.3 EMEA Polio Vaccine Price and Trend Forecast (2017-2022)
    11.2 EMEA Polio Vaccine Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.3 Europe Polio Vaccine Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.4 Middle Eastt Polio Vaccine Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.5 Africa Polio Vaccine Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.6 EMEA Polio Vaccine Sales Forecast by Type (2017-2022)
    11.7 EMEA Polio Vaccine Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer